Ivim Health vs MEDVi: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher

52 providers verified independently·Independent research·How we rank →

Ivim Health beats MEDVi overall, scoring 7.9/10 vs 7.7/10. Ivim Health is more affordable at $150/mo vs $179/mo. Choose Ivim Health for users who want personalized dosing with frequent provider ch. Choose MEDVi for users who want a low entry price with oral and injectable co.

A side-by-side look at Ivim Health and MEDVi to help you decide. We compare them on:

•Starting price per month
•Our overall score, out of 10
•Medication type, brand-name or compounded
•Whether they accept insurance
•Who each one is best for

Higher Rated

Ivim Health

#8 of 52

7.9/10

Personalized GLP-1 program with frequent provider check-ins and customized dosing schedules at an affordable price point.

Visit Ivim Health

MEDVi

#20 of 52

7.7/10

MEDVi is a compounded GLP-1 telehealth platform offering both oral tablets and injectable semaglutide and tirzepatide, with micro-dosing options for side-effect-sensitive patients. $179/mo entry pricing, free shipping, and a streamlined intake, one of the broader compounded mixes among independent telehealth providers in 2026.

Visit MEDVi

Feature	Ivim Health	MEDVi
Our Score	7.9/10	7.7/10
Starting Price	$150/mo	$179/mo
Medication Type	Both	Both
Insurance Accepted	No	No
Best For	Users who want personalized dosing with frequent provider check-ins	Users who want a low entry price with oral and injectable compounded options
Ranking	#8	#20
Get started	Visit Ivim Health	Visit MEDVi

Pros & Cons Compared

Ivim Health

Pros

+$75/mo starting price is among the lowest in the market for a program with actual provider oversight
+Bi-weekly provider check-ins included, more frequent than most platforms at this price point
+Personalized titration schedules based on individual tolerance, not cookie-cutter dose escalation
+Both brand-name and compounded available, with the option to switch based on response

Cons

−The $75/mo starting price increases with dose, expect $150-200/mo at maintenance doses
−No insurance billing, and the cost increase at higher doses isn't always clearly communicated upfront

MEDVi

Pros

+One of the few compounded providers offering both oral tablets and injectable semaglutide
+Micro-dosing options available, can start at sub-standard doses for patients concerned about side effects
+Sleek onboarding experience with clear progress tracking through their patient portal
+$179/mo is competitive for a platform with both oral and injectable compounded formulations

Cons

−No brand-name Wegovy or Zepbound on the platform (the 2026 expansion added branded Ozempic only)
−No insurance accepted, and oral compounded semaglutide has less clinical data than injectable forms; you can switch to injectable anytime at no extra fee if results lag

Our Verdict

Ivim Health edges out MEDVi with a score of 7.9/10 vs 7.7/10. If budget is your priority, Ivim Health starts at $150/mo compared to MEDVi's $179/mo. Choose Ivim Health if you want: users who want personalized dosing with frequent provider check-ins. Choose MEDVi if you want: users who want a low entry price with oral and injectable compounded options.

Still undecided? Editor's Featured Pick

Yucca Health

$146/mo · 7.7/10 · Compounded

If neither Ivim Health nor MEDVi feels like the right fit, our featured pick across all 52 GLP-1 telehealth providers is Yucca Health. It is not the highest-scored provider in our full rankings. We feature it for its low-friction value: a flat $146/mo that stays the same at every dose.

Visit Yucca Health→Read our full Yucca Health review